Montelukast Completed Phase N/A Trials for Mild Persistent Asthma / Rhinitis, Allergic, Perennial Prevention

IndicationsStatusPurposePhase
CompletedPreventionNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01581710Response of FeNO, Small Airway Dysfunction and Lung Heterogeneity to 2-week Montelukast Treatment in Asthmatic Children.